Health Catalyst Executives to Present at 43rd Annual J.P. Morgan Healthcare Conference
Health Catalyst Executives to Present at 43rd Annual J.P. Morgan Healthcare Conference
Health Catalyst will present on Wednesday, January 15, 2025, at 10:30 am PT during the conference.Health Catalyst executives will present at the J.P. Morgan Healthcare Conference on January 15, 2025.
Health Catalyst的高管將於2025年1月15日在J.P.摩根醫療保健會議上進行演講。
Quiver AI Summary
Quiver AI 概要
Health Catalyst, a leading provider of data and analytics technology for healthcare organizations, announced that its executives will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation scheduled for January 15, 2025, at 10:30 am PT. The event will feature CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight. Interested parties can access the webcast and presentation materials on their investor relations website. Health Catalyst aims to drive significant improvements in healthcare through data-informed decisions, utilizing their cloud-based platform and expertise derived from over 100 million patient records.
Health Catalyst是一家爲醫療機構提供數據和分析技術的領先供應商，宣佈其高管將參加第43屆J.P.摩根醫療保健會議，會議將在舊金山舉行，演講安排在2025年1月15日，時間爲太平洋時間上午10:30。此次活動將有首席執行官Dan Burton、首席財務官Jason Alger、首席運營官Dan LeSueur及投資者關係副總裁Jack Knight出席。感興趣的各方可以在他們的投資者關係網站上訪問網絡直播和演示材料。Health Catalyst旨在通過數據驅動的決策推動醫療保健的顯著改進，利用其基於雲的平台和來自超過10000萬患者記錄的專業知識。
Potential Positives
潛在的積極因素
- Health Catalyst will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference, enhancing visibility and credibility among investors and industry leaders.
- The participation of key executives highlights the company's commitment to engaging stakeholders and sharing its vision for data-informed healthcare improvements.
- The webcast and presentation materials will be accessible online, allowing a wider audience to engage with the company's insights and developments.
- Health Catalyst將在享有盛譽的第43屆J.P.摩根醫療保健會議上進行演講，增強在投資者和行業領袖中的可見度和信譽。
- 關鍵高管的參與凸顯了公司與利益相關者互動以及分享其數據驅動的醫療保健改進願景的承諾。
- 網絡直播和演示材料將在線提供，使更廣泛的受衆能夠參與公司見解和發展。
Potential Negatives
潛在負面因素
- None
- 無
FAQ
常見問題
What is the 43rd Annual J.P. Morgan Healthcare Conference?
第43屆摩根大通醫療大會是什麼？
The J.P. Morgan Healthcare Conference is a major event where healthcare companies share insights and innovations with investors and industry leaders.
摩根大通醫療大會是一個重要的活動，醫療公司與投資者和行業領導者分享見解和創新。
When will Health Catalyst present at the conference?
Health Catalyst將在大會上什麼時候發表演講？
Health Catalyst will present on Wednesday, January 15, 2025, at 10:30 am PT during the conference.
Health Catalyst將在2025年1月15日（星期三）太平洋時間上午10:30期間發表演講。
Who is participating in the Health Catalyst presentation?
誰將參加Health Catalyst的演講？
Dan Burton, Jason Alger, Dan LeSueur, and Jack Knight will participate in the Health Catalyst presentation.
Dan Burton、Jason Alger、Dan LeSueur和Jack Knight將參加Health Catalyst的演講。
Where can I find the webcast and presentation materials?
我在哪裏可以找到網絡廣播和演示材料？
The webcast link and related presentation materials will be available online at
網絡廣播鏈接和相關演示材料將在網上提供，
What services does Health Catalyst provide to healthcare organizations?
Health Catalyst爲醫療組織提供什麼服務？
Health Catalyst provides data and analytics technology, services, and a cloud-based platform for informed decision-making in healthcare.
Health Catalyst提供數據和分析技術、服務，以及一個基於雲的平台，以便在醫療健康領域做出明智的決策。
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
免責聲明：這是由GlobeNewswire分發的新聞稿的人工智能生成摘要。用於總結這份稿件的模型可能會出錯。請在這裏查看完整發布。
$HCAT Insider Trading Activity
$HCAt內部交易活動
$HCAT insiders have traded $HCAT stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
$HCAt內部人士在過去6個月內在公開市場交易了$HCAt股票18次。 在這些交易中，0次爲購買，18次爲出售。
Here's a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:
以下是內部人士在過去6個月內對$HCAt股票的近期交易明細：
- DANIEL LESUEUR (Chief Operating Officer) has traded it 6 times. They made 0 purchases and 6 sales, selling 51,745 shares.
- KEVIN LEE FREEMAN (Chief Commercial Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 22,500 shares.
- LINDA LLEWELYN (Chief People Officer) has traded it 6 times. They made 0 purchases and 6 sales, selling 7,921 shares.
- BENJAMIN LANDRY (General Counsel) sold 2,466 shares.
- JASON ALGER (Chief Financial Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 5,722 shares.
- 丹尼爾·勒蘇爾（首席運營官）交易了6次。期間他們沒有購買，進行了6次出售，賣出了51,745股。
- 凱文·李·弗里曼（首席商務官）交易了3次。期間他們沒有購買，進行了3次出售，賣出了22,500股。
- 琳達·劉埃林（首席人事官）交易了6次。期間他們沒有購買，進行了6次出售，賣出了7,921股。
- 本傑明·蘭德里（首席法律顧問）出售了2,466股。
- 傑森·阿爾傑（首席財務官）交易了2次。期間他們沒有購買，進行了2次出售，賣出了5,722股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟蹤內部交易，請查看Quiver Quantitative的內部交易特斯拉-儀表。
$HCAT Hedge Fund Activity
$HCAt對沖基金活動
We have seen 75 institutional investors add shares of $HCAT stock to their portfolio, and 104 decrease their positions in their most recent quarter.
我們看到75位機構投資者在其最新的季度中增加了$HCAt股票的持股數量，而104位則減少了其持股。
Here are some of the largest recent moves:
以下是最近的一些重大變動：
- NEPSIS INC. added 851,448 shares (+67.9%) to their portfolio in Q3 2024
- INVENOMIC CAPITAL MANAGEMENT LP removed 850,581 shares (-100.0%) from their portfolio in Q3 2024
- FRED ALGER MANAGEMENT, LLC added 842,509 shares (+inf%) to their portfolio in Q3 2024
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 688,905 shares (-86.0%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 686,441 shares (-28.4%) from their portfolio in Q3 2024
- PORTOLAN CAPITAL MANAGEMENT, LLC added 663,602 shares (+inf%) to their portfolio in Q3 2024
- IMPAX ASSET MANAGEMENT GROUP PLC added 360,201 shares (+16.4%) to their portfolio in Q3 2024
- NEPSIS INC. 在2024年第三季度增加了851,448股 (+67.9%) 到他們的投資組合中
- INVENOMIC CAPITAL MANAGEMENt LP 在2024年第三季度從他們的投資組合中移除了850,581股 (-100.0%)
- FRED ALGER MANAGEMENt, LLC 在2024年第三季度增加了842,509股 (+inf%) 到他們的投資組合中
- JACOBS LEVY EQUITY MANAGEMENt, INC 在2024年第三季度從他們的投資組合中移除了688,905股 (-86.0%)
- MILLENNIUm MANAGEMENt LLC 在2024年第三季度從他們的投資組合中移除了686,441股 (-28.4%)
- PORTOLAN CAPITAL MANAGEMENt, LLC 在2024年第三季度增加了663,602股 (+inf%) 到他們的投資組合中
- IMPAX ASSEt MANAGEMENt GROUP PLC 在2024年第三季度增加了360,201股 (+16.4%) 到他們的投資組合中
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟蹤對沖基金的股票投資組合，請查看Quiver Quantitative的機構持有情況儀表。
Full Release
完整發布
SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at
.
SALt LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am Pt. The webcast link and related presentation materials will be available online at
.
About Health Catalyst
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 10000萬 patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Health Catalyst Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
ir@healthcatalyst.com
Jack Knight
副總裁，投資者關係
+1 (855) 309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact:
Health Catalyst媒體聯繫人：
Amanda Flanders
Senior Vice President, Marketing and Communications
media@healthcatalyst.com
阿曼達·弗蘭德斯
營銷和通訊高級副總裁
media@healthcatalyst.com
